Concurrent Investment Advisors, LLC Adma Biologics, Inc. Transaction History
Concurrent Investment Advisors, LLC
- $5.17 Trillion
- Q2 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 11,095 shares of ADMA stock, worth $159,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,095
Previous 10,122
9.61%
Holding current value
$159,768
Previous $201 Million
0.55%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
401Shares Held
191MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$308 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$268 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$185 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$174 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$85.1 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.83B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...